Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Not Yet Recruiting

TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT06598969

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Hospital Universitario Virgen del Rocío Seville, Spain

View Trial Details

Not Yet Recruiting

ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML

NCT06463327

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS

NCT06050941

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial

NCT06235398

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Role of BMP Pathway in MDS Progression

NCT06175923

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Hospices Civils de Lyon Lyon, France

View Trial Details

Not Yet Recruiting

Lifestyle-modifying Interventions in Low-risk MDS Patients

NCT05433805

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome

NCT03672539

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Bone Marrow Diseases, Chronic Disease, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

NCT02719574

Conditions: Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +9 more
Locations: UCLA Medical Center Los Angeles, California, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

Yale University New Haven, Connecticut, United States

University of Miami Miami, Florida, United States

View all 60 locations

View Trial Details

Completed

Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes

NCT01192425

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +17 more
Locations: Not specified

View Trial Details

Completed

A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

NCT05024994

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: University of Miami (Data Collection AND Specimen Analysis Only) Miami, Florida, United States

Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions